1. Home
  2. VNRX vs PDSB Comparison

VNRX vs PDSB Comparison

Compare VNRX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • PDSB
  • Stock Information
  • Founded
  • VNRX N/A
  • PDSB 2005
  • Country
  • VNRX United States
  • PDSB United States
  • Employees
  • VNRX N/A
  • PDSB N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VNRX Health Care
  • PDSB Health Care
  • Exchange
  • VNRX Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • VNRX 68.3M
  • PDSB 72.2M
  • IPO Year
  • VNRX N/A
  • PDSB N/A
  • Fundamental
  • Price
  • VNRX $0.60
  • PDSB $1.20
  • Analyst Decision
  • VNRX Strong Buy
  • PDSB Strong Buy
  • Analyst Count
  • VNRX 4
  • PDSB 2
  • Target Price
  • VNRX $3.50
  • PDSB $10.00
  • AVG Volume (30 Days)
  • VNRX 196.8K
  • PDSB 582.9K
  • Earning Date
  • VNRX 08-14-2025
  • PDSB 08-13-2025
  • Dividend Yield
  • VNRX N/A
  • PDSB N/A
  • EPS Growth
  • VNRX N/A
  • PDSB N/A
  • EPS
  • VNRX N/A
  • PDSB N/A
  • Revenue
  • VNRX $1,319,252.00
  • PDSB N/A
  • Revenue This Year
  • VNRX $274.46
  • PDSB N/A
  • Revenue Next Year
  • VNRX $212.60
  • PDSB N/A
  • P/E Ratio
  • VNRX N/A
  • PDSB N/A
  • Revenue Growth
  • VNRX 35.10
  • PDSB N/A
  • 52 Week Low
  • VNRX $0.40
  • PDSB $0.85
  • 52 Week High
  • VNRX $0.94
  • PDSB $4.29
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 39.24
  • PDSB 47.89
  • Support Level
  • VNRX $0.64
  • PDSB $1.15
  • Resistance Level
  • VNRX $0.73
  • PDSB $1.31
  • Average True Range (ATR)
  • VNRX 0.04
  • PDSB 0.09
  • MACD
  • VNRX -0.00
  • PDSB 0.00
  • Stochastic Oscillator
  • VNRX 19.34
  • PDSB 15.63

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: